Movement Alert｜GenScript Biotech Falls 5.19% in Regular Trading, Post-ASCO Profit-Taking Continues Amid Sector Weakness

Market Focus11:08

On June 1, GenScript Biotech fell 5.19% in regular trading, trading at HKD 12.98/share, with trading volume of HKD 116 million.

The decline represents a continuation of profit-taking following the ASCO annual meeting catalyst. GenScript's associate company Legend Biotech presented multiple research results at the ASCO conference, including Phase 1 clinical data for LB2102, a DLL3-targeting CAR-T therapy for relapsed or refractory small cell lung cancer, alongside new CARVYKTI data. This news had driven the stock up over 5% on May 27, but subsequent sessions have seen sustained selling pressure as the positive catalyst was fully digested.

Adding to downside pressure, Hong Kong Stock Connect channels recorded consecutive large-scale net outflows in recent sessions, raising concerns that institutional investors leveraged the ASCO rally to reduce positions. At the sector level, the Life Sciences Tools and Services space broadly weakened, with Insilico Medicine down 6.88%, XtalPi down 2.79%, and WuXi XDC down 2.19%, amplifying the sector-wide drag on GenScript.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1143553345?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-01 11:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143553345","market":"hk","top_or_hot":-1,"title":"Movement Alert｜GenScript Biotech Falls 5.19% in Regular Trading, Post-ASCO Profit-Taking Continues Amid Sector Weakness","media":"Market Focus","content":"<p><p>On June 1, GenScript Biotech fell 5.19% in regular trading, trading at HKD 12.98/share, with trading volume of HKD 116 million.</p><p>The decline represents a continuation of profit-taking following the ASCO annual meeting catalyst. GenScript's associate company Legend Biotech presented multiple research results at the ASCO conference, including Phase 1 clinical data for LB2102, a DLL3-targeting CAR-T therapy for relapsed or refractory small cell lung cancer, alongside new CARVYKTI data. This news had driven the stock up over 5% on May 27, but subsequent sessions have seen sustained selling pressure as the positive catalyst was fully digested.</p><p>Adding to downside pressure, Hong Kong Stock Connect channels recorded consecutive large-scale net outflows in recent sessions, raising concerns that institutional investors leveraged the ASCO rally to reduce positions. At the sector level, the Life Sciences Tools and Services space broadly weakened, with Insilico Medicine down 6.88%, XtalPi down 2.79%, and WuXi XDC down 2.19%, amplifying the sector-wide drag on GenScript.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜GenScript Biotech Falls 5.19% in Regular Trading, Post-ASCO Profit-Taking Continues Amid Sector Weakness</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜GenScript Biotech Falls 5.19% in Regular Trading, Post-ASCO Profit-Taking Continues Amid Sector Weakness\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-01 11:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 1, GenScript Biotech fell 5.19% in regular trading, trading at HKD 12.98/share, with trading volume of HKD 116 million.</p><p>The decline represents a continuation of profit-taking following the ASCO annual meeting catalyst. GenScript's associate company Legend Biotech presented multiple research results at the ASCO conference, including Phase 1 clinical data for LB2102, a DLL3-targeting CAR-T therapy for relapsed or refractory small cell lung cancer, alongside new CARVYKTI data. This news had driven the stock up over 5% on May 27, but subsequent sessions have seen sustained selling pressure as the positive catalyst was fully digested.</p><p>Adding to downside pressure, Hong Kong Stock Connect channels recorded consecutive large-scale net outflows in recent sessions, raising concerns that institutional investors leveraged the ASCO rally to reduce positions. At the sector level, the Life Sciences Tools and Services space broadly weakened, with Insilico Medicine down 6.88%, XtalPi down 2.79%, and WuXi XDC down 2.19%, amplifying the sector-wide drag on GenScript.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01548","symbol_name":"金斯瑞生物科技","start_time":0,"source_url":"","article_id":"1143553345","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143553345","pubTimestamp":1780283336,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 1, GenScript Biotech fell 5.19% in regular trading, trading at HKD 12.98/share, with trading volume of HKD 116 million.The decline represents a continuation of profit-taking following the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01548":"金斯瑞生物科技"},"translate_title":"动向提示|金斯瑞生物常规交易跌5.19%板块疲软下ASCO后获利回吐持续","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01548":1},"content_text":"On June 1, GenScript Biotech fell 5.19% in regular trading, trading at HKD 12.98/share, with trading volume of HKD 116 million.The decline represents a continuation of profit-taking following the ASCO annual meeting catalyst. GenScript's associate company Legend Biotech presented multiple research results at the ASCO conference, including Phase 1 clinical data for LB2102, a DLL3-targeting CAR-T therapy for relapsed or refractory small cell lung cancer, alongside new CARVYKTI data. This news had driven the stock up over 5% on May 27, but subsequent sessions have seen sustained selling pressure as the positive catalyst was fully digested.Adding to downside pressure, Hong Kong Stock Connect channels recorded consecutive large-scale net outflows in recent sessions, raising concerns that institutional investors leveraged the ASCO rally to reduce positions. At the sector level, the Life Sciences Tools and Services space broadly weakened, with Insilico Medicine down 6.88%, XtalPi down 2.79%, and WuXi XDC down 2.19%, amplifying the sector-wide drag on GenScript.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1143553345","isCrawlerRequest":true}